GW Pharmaceuticals - Stock Split History | GWPH
Stock split history for GW Pharmaceuticals since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
|GW Pharmaceuticals Annual Stock Splits
|GW Pharmaceuticals Quarterly Stock Splits
||Medical Products Manufacturing
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.